The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge. (HomeCoMe)
The Effect of a Home-based Community Pharmacist-led Medication Management Program (HomeCoMe-program) Complementary to an In-hospital Medication Reconciliation Program on Drug-related Problems Post-discharge: A Prospective Cohort Study.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Flevoland
-
Almere, Flevoland, Países Bajos, 1315RA
- Zorgapotheken Flevoland
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- patient uses more than three prescribed systemic drugs intended for chronic use at admission and discharge
- patient has an expected length of stay of 48 hours or longer
Exclusion Criteria:
- Patients admitted for scheduled chemotherapy
- Patients admitted for radiation therapy
- Patients admitted for transplantation
- Patients transferred from another hospital
- Patients transferred from another non-eligible ward within the same hospital
- No informed consent signed
- A live expectancy less than 6 months
- Inability to be counselled (e.g. cognitive dysfunction, language constraints who cannot be solved with an interpreter)
- Discharge to a nursing home (presuming dependence on medication administration)
- If patients' community pharmacy is not participating in this study
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: HomeCoMe-program group
the arm receiving the pharmacist home visit
|
A home visit by patients own community pharmacist within seven days after hospital discharge.
The community pharmacist will perform a semi-structured interview on (1) use of the prescribed medication, (2) ADEs, (3) adherence issues, by (A) assessing patient's needs and concerns around his pharmacotherapy, (B) identifying and solving obstacles for medicines intake, (C) checking on the need for a compliance aid, (D) collecting spare medication and finally (4) knowledge on medication use, when to take which medicine and why, and medication changes made during the hospitalisation.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Identifying and solving adverse drug events (ADEs) and other drug-related problems (DRPs) post-discharge
Periodo de tiempo: within 7 days post-discharge
|
The total number of assessed and solved ADEs post-discharge will be measured. Assessing and solving ADEs takes place during the pharmacist home visit. Using START-STOPP criteria on patients medication records, ADEs will also be compared between the intervention and usual care group. |
within 7 days post-discharge
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Improvement of adherence to medication at hospital discharge
Periodo de tiempo: up to 6 months after discharge
|
The "medication possession ratio" will be calculated retrospectively from pharmacy dispensing data after 6 months to investigate patient's adherence and compared between the intervention and control group.
|
up to 6 months after discharge
|
|
Patient assessment of medication knowledge at time of home visit
Periodo de tiempo: within 7 days after discharge
|
At time of the home visit patients are asked about their knowledge (e.g.
indication, dose regime, etc) regarding the medication they are taking.
Knowledge is scored and lack of knowledge is solved by teaching the patient.
|
within 7 days after discharge
|
|
Types of interventions made at the pharmacist home visit
Periodo de tiempo: within 7 days after discharge
|
The types of intervention the pharmacist works on during the 7 day follow-up home visit are assessed.
|
within 7 days after discharge
|
|
Patient satisfaction with the pharmacist home visit
Periodo de tiempo: Immediately after receiving the home visit
|
The satisfaction survey consists of 13 interview questions, where the subject subjectively scores each question on a four-point scale, developed specifically for this study.
|
Immediately after receiving the home visit
|
|
Assessment of patient reported health rating
Periodo de tiempo: at 14 days after discharge
|
Patient are asked by telephone to report their health on a scale from 1 (worst imaginable health) to 10 (best imaginable health).
Number are compared between the intervention and control group.
|
at 14 days after discharge
|
|
General practitioners satisfaction with the pharmacist home visit
Periodo de tiempo: Immediately after the home visit is executed
|
The satisfaction survey consists of 13 interview questions, where the subject subjectively scores each question on a four-point scale, developed specifically for this study.
|
Immediately after the home visit is executed
|
|
Assessment of patient reported health rating
Periodo de tiempo: at 42 days after discharge
|
Patient are asked by telephone to report their health on a scale from 1 (worst imaginable health) to 10 (best imaginable health).
Number are compared between the intervention and control group.
|
at 42 days after discharge
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Marcel L Bouvy, Prof, PharmD, PhD, UIPS
Publicaciones y enlaces útiles
Publicaciones Generales
- Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006 Mar 13;166(5):565-71. doi: 10.1001/archinte.166.5.565.
- Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002 Dec;54(6):657-64. doi: 10.1046/j.1365-2125.2002.01707.x.
- Kwint HF, Faber A, Gussekloo J, Bouvy ML. The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther. 2012 Dec;37(6):674-80. doi: 10.1111/j.1365-2710.2012.01370.x. Epub 2012 Aug 3.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- ZGA-1
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .